Natee Meepian / iStockphoto.com
2 November 2018Americas
Illumina buys rival Pacific Biosciences for $1.2bn
Gene-sequencing company Illumina has agreed to buy competitor Pacific Biosciences (PacBio) for $1.2 billion.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
30 September 2019 Taiwan-based Personal Genomics Taiwan has taken gene-sequencing rival Pacific Biosciences to court in the US, over alleged patent infringement.
Genetics
3 January 2020 Gene-sequencing companies Illumina and Pacific Biosciences have “mutually agreed” to terminate their $1.2 million merger agreement, under which Illumina would have acquired PacBio.
Editor's picks
Editor's picks
Americas
30 September 2019 Taiwan-based Personal Genomics Taiwan has taken gene-sequencing rival Pacific Biosciences to court in the US, over alleged patent infringement.
Genetics
3 January 2020 Gene-sequencing companies Illumina and Pacific Biosciences have “mutually agreed” to terminate their $1.2 million merger agreement, under which Illumina would have acquired PacBio.
Americas
30 September 2019 Taiwan-based Personal Genomics Taiwan has taken gene-sequencing rival Pacific Biosciences to court in the US, over alleged patent infringement.
Genetics
3 January 2020 Gene-sequencing companies Illumina and Pacific Biosciences have “mutually agreed” to terminate their $1.2 million merger agreement, under which Illumina would have acquired PacBio.